Obesity News and Research

Latest Obesity News and Research

Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment

Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.

23 Jun 2010

Preschool children with tooth decay more likely to be obese: Study

Preschool children with tooth decay may be more likely to be overweight or obese than the general population and, regardless of weight, are more likely to consume too many calories, a new study indicates. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

High blood sugar in mother during pregnancy leads to reduced insulin sensitivity in children

Children of mothers whose blood glucose (sugar) was high during pregnancy are more likely to have low insulin sensitivity—a risk factor for type 2 diabetes—even after taking into consideration the children's body weight, a new study shows. The results will be presented Tuesday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

Public health program to migrant preschool children helps reduce risk of obesity: Study

Migrant children are at increased risk of obesity, but a new study shows that a program teaching multiple lifestyle changes to predominantly migrant preschoolers and their parents helps the children reduce body fat and improve fitness. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

Weight gain after age of 50 is associated with increased risk of diabetes after 65 years

For individuals 65 years of age and older, obesity, excess body fat around the waist and gaining weight after the age of 50 are associated with an increased risk of diabetes, according to a study in the June 23/30 issue of JAMA.

23 Jun 2010

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

A new nationwide study finds that some local health clinics do not offer diabetes screening or obesity prevention programs to their clients, who tend to be poor. The clinics need to be "armed and equipped" to respond to the growing threat from type 2 diabetes and obesity in the United States, said researcher and study co-author Ann Albright. "These are huge problems that we're facing. We want to be sure that we're responding effectively."

23 Jun 2010

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.

23 Jun 2010

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Ethicon Endo-Surgery, Inc. (EES) today announced it has renewed its research collaboration agreement with the University of Cincinnati (UC) and its Metabolic Diseases Institute (MDI). The three-year, $13.5M grant extension, is part of the EES Metabolic Applied Research Strategy (MARS), which also includes research from GI Metabolism Laboratory and Weight Center at the Massachusetts General Hospital (MGH).

22 Jun 2010

Fructose makes cells mature into fat cells in belly fat, study finds

Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.

22 Jun 2010

Data on Qnexa to be featured in six presentations at ADA annual meeting

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be featured in a total of six presentations – including an oral presentation, three moderated poster presentations and two poster presentations – during the 70th Scientific Sessions of the American Diabetes Association, being held from June 25-29, 2010 in Orlando, Florida.

22 Jun 2010

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

People who donate one of their kidneys experience faster deterioration of their other kidney if they have the metabolic syndrome at the time of donation, a new study finds. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Novel MC4R agonist exhibits potential as new treatment for obesity, diabetes

Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.

22 Jun 2010

Women with PCOS may be more vulnerable to BPA exposure: Study

Women with the polycystic ovary syndrome, the most common hormone imbalance in women of reproductive age, may be more vulnerable to exposure to the chemical bisphenol A, found in many plastic household items, according to a new study. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

The "hunger" hormone ghrelin, which acts in the brain to stimulate hunger and increase food intake, heightens the appeal of high-calorie foods over low-calorie foods, according to a study that will be presented Tuesday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Gastric bypass surgery improves insulin sensitivity in Type 2 diabetes patients

Gastric bypass surgery improves Type 2 diabetes by other mechanisms in addition to weight loss and does so better than a low-calorie diet despite achieving equal weight loss, a new study finds. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

21 Jun 2010

PHCG recognized with CEO Cancer Gold Standard accreditation in fight against cancer

Publicis Healthcare Communications Group, the world's largest healthcare communications group, has received CEO Cancer Gold Standard accreditation, recognizing the organization's commitment to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

21 Jun 2010

Spark Together for Health Kids program promotes access to physical activity, healthy food

A new survey by the Heart and Stroke Foundation of Ontario found the majority of kids in the Greater Toronto Area (GTA) will be missing out on physical activity this summer, as parents scramble to find child care solutions once school is out.

21 Jun 2010

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.

21 Jun 2010

Metabolically healthy obese people appear to have protection against cardiovascular disease: Study

Obese people without metabolic risk factors for diabetes and heart disease, such as high blood pressure and cholesterol, do not have the elevated cardiovascular risk typical of obesity, but they represent only a small percentage of the obese population, according to a long-term study. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego

21 Jun 2010

Research findings open door to new model for health and fitness measurement

A University of Southern California study appearing in the current issue of peer-review journal, Nutrition Research reports that the user-friendly, Web-native Stayhealthy BC1 System offers clinical-grade body composition analysis comparable to the most rigorous clinical tools. According to the company, the study's findings open the door to a new, far more effective and engaging model for health and fitness measurement, reporting body composition analysis, rather than body weight or the outdated body mass index.

19 Jun 2010

Obesity News and Research

Latest Obesity News and Research

Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment

Preschool children with tooth decay more likely to be obese: Study

High blood sugar in mother during pregnancy leads to reduced insulin sensitivity in children

Public health program to migrant preschool children helps reduce risk of obesity: Study

Weight gain after age of 50 is associated with increased risk of diabetes after 65 years

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Fructose makes cells mature into fat cells in belly fat, study finds

Data on Qnexa to be featured in six presentations at ADA annual meeting

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

Novel MC4R agonist exhibits potential as new treatment for obesity, diabetes

Women with PCOS may be more vulnerable to BPA exposure: Study

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

Gastric bypass surgery improves insulin sensitivity in Type 2 diabetes patients

PHCG recognized with CEO Cancer Gold Standard accreditation in fight against cancer

Spark Together for Health Kids program promotes access to physical activity, healthy food

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Metabolically healthy obese people appear to have protection against cardiovascular disease: Study

Research findings open door to new model for health and fitness measurement

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Obesity News and Research

Latest Obesity News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in